This inventor holds 1 USPTO granted patent. Top assignee: Daiichi Sankyo Company, Limited. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Michiko Kitamura: Innovator in Antibody-Pyrrolobenzodiazepine Research
Introduction
Michiko Kitamura is a prominent inventor based in Tokyo, Japan. She has made significant contributions to the field of biochemistry, particularly in the development of innovative therapeutic agents. Her work focuses on the combination of antibody-pyrrolobenzodiazepine derivative conjugates and PARP inhibitors.
Latest Patents
Kitamura holds 1 patent for her groundbreaking invention titled "Combination of Antibody-Pyrrolobenzodiazepine Derivative Conjugate and PARP Inhibitor." This patent represents a significant advancement in targeted cancer therapies, showcasing her expertise in the intersection of immunology and pharmacology.
Career Highlights
Throughout her career, Michiko Kitamura has been associated with Daiichi Sankyo Company, Limited, a leading pharmaceutical company known for its commitment to innovative drug development. Her role at Daiichi Sankyo has allowed her to collaborate with other experts in the field and contribute to the advancement of medical science.
Collaborations
One of her notable collaborators is Naoya Harada, with whom she has worked closely on various research projects. Their partnership exemplifies the collaborative spirit that drives innovation in the pharmaceutical industry.
Conclusion
Michiko Kitamura's contributions to the field of biochemistry and her innovative patent highlight her role as a leading inventor in Japan. Her work continues to inspire advancements in targeted therapies, making a significant impact on the future of medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile